Skip to main content
. 2019 Dec 18;12(1):1688616. doi: 10.1080/19420862.2019.1688616

Figure 7.

Figure 7.

Observed and individual model fitted profiles for anti-EGFR CAR-T induced tumor growth inhibition. Intracranial xenograft mice, inoculated with EGFR-expressing U87 cells (Day 0), were treated with intratumoral (IT) administration of (1) PBS vehicle control (profiles in black), (2) 1 million high-affinity cetuximab CAR-T cells (profiles in red) and (3) 1 million low-affinity nimotuzumab CAR-T cells (profiles in blue) in a Q1WX3 dosing regimen, starting at day 4.